In transgenic mouse models of AD, riluzole modulated the activity of small conductance and Ca2+-activated K+ channels (SK channels), decreased Aβ levels (oligomers and plaques) and Tau pathology (total level and phosphorylation), and reversed changes in gene expression [180,181,182]. This evidence concerns the gene MAPT and Alzheimer disease.